Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 12 (3), 206-208

Fecal Microbiota Transplantation: An Ambiguous Translational Pathway for a Promising Treatment

Affiliations

Fecal Microbiota Transplantation: An Ambiguous Translational Pathway for a Promising Treatment

Josiane Joseph et al. Clin Transl Sci.

Conflict of interest statement

The authors declared no competing interests for this work.

Figures

Figure 1
Figure 1
Timeline of significant events pertinent to the translation of fecal microbiota transplantation (FMT) for C. difficile colitis. FDA, US Food and Drug Administration.

Similar articles

See all similar articles

References

    1. Bakken J.S. et al Treating Clostridium difficile infection with fecal microbiota transplantation. Clin. Gastroenterol. Hepatol. 9, 1044–1049 (2011). - PMC - PubMed
    1. Lessa F.C. et al Burden of Clostridium difficile infection in the United States. N. Engl. J. Med. 372, 825–834 (2015). - PubMed
    1. Kelly C.R. et al Update on fecal microbiota transplantation 2015: indications, methodologies, mechanisms, and outlook. Gastroenterology 149, 223–237 (2015). - PMC - PubMed
    1. Eiseman B., Silen W., Bascom G.S. & Kauvar A.J. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 44, 854–859 (1958). - PubMed
    1. Schwan A., Sjolin S., Trottestam U. & Aronsson B. Relapsing Clostridium difficile enterocolitis cured by rectal infusion of homologous faeces. Lancet 2, 845 (1983). - PubMed

LinkOut - more resources

Feedback